BNP Paribas Financial Markets’s Legend Biotech LEGN Stock Holding History

BNP Paribas Financial Markets’s Portfolio LEGN Stock Details LEGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.26M	Buy	251,449 +16,916	+7%	+$456K	﹤0.01%	1835
2026 Q1	$4.24M	Sell	234,533 -30,390	-11%	-$579K	﹤0.01%	2149
2025 Q4	$5.76M	Buy	264,923 +21,341	+9%	+$611K	﹤0.01%	1956
2025 Q3	$7.94M	Buy	243,582 +48,522	+25%	+$1.79M	﹤0.01%	1686
2025 Q2	$6.92M	Sell	195,060 -33,633	-15%	-$1.09M	﹤0.01%	1669
2025 Q1	$7.76M	Sell	228,693 -15,296	-6%	-$549K	﹤0.01%	1547
2024 Q4	$7.94M	Buy	+243,989	New	+$10.1M	﹤0.01%	1507
2024 Q1	–	Sell	-1,752	Closed	-$105K	–	4152
2023 Q4	$105K	Buy	+1,752	New	+$111K	﹤0.01%	3381

Other funds holding LEGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

BNP Paribas Financial Markets's LEGN Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its Legend Biotech (LEGN) stake by 7.2% in Q2 2026, buying an estimated $456K and bringing the position to 251,449 shares worth $7.26M. The position accounts for ﹤0.01% of the portfolio, ranked #1835.

BNP Paribas Financial Markets first reported a position in LEGN in Q4 2023 and has held it in 8 quarters since. The position peaked at $7.94M in Q3 2025. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

BNP Paribas Financial Markets held 251,449 shares of Legend Biotech worth $7.26M as of Q2 2026.
BNP Paribas Financial Markets bought 16,916 Legend Biotech shares in Q2 2026, an estimated $456K.
Legend Biotech made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #1835 holding.
BNP Paribas Financial Markets first reported a position in Legend Biotech in Q4 2023 and has held it in 8 quarters since.
BNP Paribas Financial Markets's Legend Biotech position peaked at $7.94M in Q3 2025.
219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.